Clough Capital Partners L P Fusion Pharmaceuticals Inc. Transaction History

Clough Capital Partners L P

  • $878 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$9.75 - $13.09 $3.89 Million - $5.23 Million
-399,399 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$11.5 - $13.73 $39,111 - $46,695
-3,401 Reduced 0.84%
399,399 $4.69 Million
Q2 2020

Aug 14, 2020
BUY
$17.0 - $17.78 $6.85 Million - $7.16 Million
402,800 New
402,800 $7.04 Million

Others Institutions Holding FUSN

# of Institutions
5
Shares Held
93K
Call Options Held
1.4K
Put Options Held
0
View Full List

About Fusion Pharmaceuticals Inc.

FUSN Quotes by TradingView
  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track This Portfolio

Track Clough Capital Partners L P Portfolio

Follow Clough Capital Partners L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email